(CRH) CRH - Ratings and Ratios
Cement, Aggregates, Readymixed Concrete, Asphalt, Precast Concrete
| Risk via 10d forecast | |
|---|---|
| Volatility | 26.6% |
| Value at Risk 5%th | 42.6% |
| Relative Tail Risk | -2.38% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.40 |
| Alpha | -5.19 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.453 |
| Beta | 1.199 |
| Beta Downside | 1.175 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.01% |
| Mean DD | 5.33% |
| Median DD | 3.23% |
Description: CRH CRH September 26, 2025
CRH plc, headquartered in Dublin, operates a diversified building-materials business across Ireland, the United States, the United Kingdom, the rest of Europe, and other international markets. The firm is organized into three reporting segments-Americas Materials Solutions, Americas Building Solutions, and International Solutions-each delivering aggregates, cement, ready-mix concrete, mortars, asphalt, and a broad suite of value-added construction products.
The company’s portfolio spans precast and prestressed concrete elements (floor and wall panels, beams, vaults, pipes, and manholes), polymer-based underground vaults and drainage systems, as well as engineered steel and polymer anchoring solutions. Complementary offerings include crushed stone, sand, gravel, hardscape products (pavers, blocks, curbs), fencing, railing systems, composite decking, and packaged concrete mixes for residential, commercial, infrastructure, and outdoor-living projects.
Key recent performance metrics (FY 2023) show revenue of approximately €30.5 billion, an adjusted EBITDA margin of ~12 %, and a net-debt-to-EBITDA ratio of 2.1×. The firm paid a dividend yielding about 4.3 % and returned €1.4 billion to shareholders via buy-backs and payouts, reflecting a capital-allocation policy that prioritizes cash generation.
CRH’s earnings are most sensitive to three macro drivers: (1) U.S. housing-starts and public-infrastructure spending, which together account for roughly 45 % of consolidated revenue; (2) European inflation and energy-price volatility that affect cement and steel input costs; and (3) the sector-wide transition toward low-carbon building materials, where CRH is investing in alternative cements and recycled-aggregate solutions to meet tightening EU emissions standards.
For a deeper, data-driven assessment of CRH’s valuation dynamics and scenario analysis, you may find ValueRay’s analytical tools useful.
CRH Stock Overview
| Market Cap in USD | 75,700m |
| Sub-Industry | Construction Materials |
| IPO / Inception | 1993-02-19 |
| Return 12m vs S&P 500 | -0.15% |
| Analyst Rating | 4.43 of 5 |
CRH Dividends
| Dividend Yield | 1.31% |
| Yield on Cost 5y | 4.12% |
| Yield CAGR 5y | 10.95% |
| Payout Consistency | 90.0% |
| Payout Ratio | 28.3% |
CRH Growth Ratios
| CAGR 3y | 45.57% |
| CAGR/Max DD Calmar Ratio | 1.69 |
| CAGR/Mean DD Pain Ratio | 8.54 |
| Current Volume | 3125.4k |
| Average Volume | 3266.3k |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (3.21b TTM) > 0 and > 6% of Revenue (6% = 2.08b TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA 0.05pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 15.20% (prev 12.88%; Δ 2.31pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 5.28b > Net Income 3.21b (YES >=105%, WARN >=100%) |
| Net Debt (15.95b) to EBITDA (6.27b) ratio: 2.54 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.45 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (675.5m) change vs 12m ago -1.46% (target <= -2.0% for YES) |
| Gross Margin 36.12% (prev 35.27%; Δ 0.85pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 63.03% (prev 63.22%; Δ -0.18pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.01 (EBITDA TTM 6.27b / Interest Expense TTM 701.5m) >= 6 (WARN >= 3) |
Altman Z'' 3.10
| (A) 0.09 = (Total Current Assets 16.85b - Total Current Liabilities 11.60b) / Total Assets 58.53b |
| (B) 0.43 = Retained Earnings (Balance) 25.07b / Total Assets 58.53b |
| (C) 0.05 = EBIT TTM 2.81b / Avg Total Assets 54.87b |
| (D) 0.74 = Book Value of Equity 24.97b / Total Liabilities 33.90b |
| Total Rating: 3.10 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 56.06
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield 2.76% = 1.38 |
| 3. FCF Margin 7.30% = 1.83 |
| 4. Debt/Equity 0.86 = 2.14 |
| 5. Debt/Ebitda 2.54 = -1.03 |
| 6. ROIC - WACC (= 0.83)% = 1.04 |
| 7. RoE 14.51% = 1.21 |
| 8. Rev. Trend -13.44% = -1.01 |
| 9. EPS Trend 0.18% = 0.01 |
What is the price of CRH shares?
Over the past week, the price has changed by -3.15%, over one month by -5.43%, over three months by -1.86% and over the past year by +13.73%.
Is CRH a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CRH is around 133.23 USD . This means that CRH is currently undervalued and has a potential upside of +19.85% (Margin of Safety).
Is CRH a buy, sell or hold?
- Strong Buy: 14
- Buy: 5
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CRH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 133.9 | 20.4% |
| Analysts Target Price | 133.9 | 20.4% |
| ValueRay Target Price | 148.6 | 33.6% |
CRH Fundamental Data Overview November 11, 2025
P/E Trailing = 22.5549
P/E Forward = 19.305
P/S = 2.0514
P/B = 3.6364
P/EG = 2.5729
Beta = 1.195
Revenue TTM = 34.59b USD
EBIT TTM = 2.81b USD
EBITDA TTM = 6.27b USD
Long Term Debt = 10.97b USD (from longTermDebt, last fiscal year)
Short Term Debt = 4.22b USD (from shortTermDebt, last quarter)
Debt = 20.15b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.95b USD (from netDebt column, last quarter)
Enterprise Value = 91.65b USD (75.70b + Debt 20.15b - CCE 4.20b)
Interest Coverage Ratio = 4.01 (Ebit TTM 2.81b / Interest Expense TTM 701.5m)
FCF Yield = 2.76% (FCF TTM 2.53b / Enterprise Value 91.65b)
FCF Margin = 7.30% (FCF TTM 2.53b / Revenue TTM 34.59b)
Net Margin = 9.27% (Net Income TTM 3.21b / Revenue TTM 34.59b)
Gross Margin = 36.12% ((Revenue TTM 34.59b - Cost of Revenue TTM 22.09b) / Revenue TTM)
Gross Margin QoQ = 38.93% (prev 39.45%)
Tobins Q-Ratio = 1.57 (Enterprise Value 91.65b / Total Assets 58.53b)
Interest Expense / Debt = 1.04% (Interest Expense 209.0m / Debt 20.15b)
Taxrate = -22.28% (negative due to tax credits) (-428.0m / 1.92b)
NOPAT = 3.44b (EBIT 2.81b * (1 - -22.28%)) [negative tax rate / tax credits]
Current Ratio = 1.45 (Total Current Assets 16.85b / Total Current Liabilities 11.60b)
Debt / Equity = 0.86 (Debt 20.15b / totalStockholderEquity, last quarter 23.31b)
Debt / EBITDA = 2.54 (Net Debt 15.95b / EBITDA 6.27b)
Debt / FCF = 6.32 (Net Debt 15.95b / FCF TTM 2.53b)
Total Stockholder Equity = 22.09b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.48% (Net Income 3.21b / Total Assets 58.53b)
RoE = 14.51% (Net Income TTM 3.21b / Total Stockholder Equity 22.09b)
RoCE = 8.50% (EBIT 2.81b / Capital Employed (Equity 22.09b + L.T.Debt 10.97b))
RoIC = 9.33% (NOPAT 3.44b / Invested Capital 36.84b)
WACC = 8.50% (E(75.70b)/V(95.85b) * Re(10.42%) + D(20.15b)/V(95.85b) * Rd(1.04%) * (1-Tc(-0.22)))
Discount Rate = 10.42% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.14%
[DCF Debug] Terminal Value 66.39% ; FCFE base≈2.39b ; Y1≈1.99b ; Y5≈1.47b
Fair Price DCF = 27.95 (DCF Value 18.72b / Shares Outstanding 669.9m; 5y FCF grow -20.07% → 3.0% )
EPS Correlation: 0.18 | EPS CAGR: -15.12% | SUE: 0.06 | # QB: 0
Revenue Correlation: -13.44 | Revenue CAGR: -13.46% | SUE: -0.02 | # QB: 0
Additional Sources for CRH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle